BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 31.59 Million CAD | 13.12% |
| 2022 | 27.92 Million CAD | -2.42% |
| 2021 | 28.61 Million CAD | 28.15% |
| 2020 | 22.33 Million CAD | 4.24% |
| 2019 | 21.42 Million CAD | -0.48% |
| 2018 | 21.52 Million CAD | 3.68% |
| 2017 | 20.76 Million CAD | 15.85% |
| 2016 | 17.92 Million CAD | 16.47% |
| 2015 | 15.38 Million CAD | 26.02% |
| 2014 | 12.21 Million CAD | 56.56% |
| 2013 | 7.79 Million CAD | 55.24% |
| 2012 | 5.02 Million CAD | 78.88% |
| 2011 | 2.8 Million CAD | 67.06% |
| 2010 | 1.68 Million CAD | 63.24% |
| 2009 | 1.02 Million CAD | -6.54% |
| 2008 | 1.1 Million CAD | -0.21% |
| 2007 | 1.1 Million CAD | -27.08% |
| 2006 | 1.51 Million CAD | 102.33% |
| 2005 | 748.52 Thousand CAD | 5.27% |
| 2004 | 711.03 Thousand CAD | -12.53% |
| 2003 | 812.84 Thousand CAD | 52.78% |
| 2002 | 532.02 Thousand CAD | -20.11% |
| 2001 | 665.93 Thousand CAD | -24.95% |
| 2000 | 887.31 Thousand CAD | 10.91% |
| 1999 | 800 Thousand CAD | 14.29% |
| 1998 | 700 Thousand CAD | 0.0% |
| 1997 | 700 Thousand CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.94 Million CAD | 15.66% |
| 2024 Q1 | 7.73 Million CAD | -6.53% |
| 2023 Q4 | 8.27 Million CAD | -6.73% |
| 2023 Q1 | 6.48 Million CAD | -13.12% |
| 2023 Q3 | 8.87 Million CAD | 11.41% |
| 2023 FY | 31.59 Million CAD | 13.12% |
| 2023 Q2 | 7.96 Million CAD | 22.83% |
| 2022 Q2 | 6.63 Million CAD | -5.72% |
| 2022 Q1 | 7.03 Million CAD | -2.51% |
| 2022 Q3 | 6.79 Million CAD | 2.35% |
| 2022 Q4 | 7.46 Million CAD | 9.88% |
| 2022 FY | 27.92 Million CAD | -2.42% |
| 2021 Q2 | 7.28 Million CAD | -1.76% |
| 2021 Q3 | 6.69 Million CAD | -8.22% |
| 2021 Q4 | 7.21 Million CAD | 7.9% |
| 2021 Q1 | 7.41 Million CAD | 29.57% |
| 2021 FY | 28.61 Million CAD | 28.15% |
| 2020 FY | 22.33 Million CAD | 4.24% |
| 2020 Q3 | 5.77 Million CAD | 20.97% |
| 2020 Q1 | 6.06 Million CAD | 8.86% |
| 2020 Q4 | 5.72 Million CAD | -0.79% |
| 2020 Q2 | 4.77 Million CAD | -21.3% |
| 2019 Q2 | 5.15 Million CAD | 15.13% |
| 2019 FY | 21.42 Million CAD | -0.48% |
| 2019 Q3 | 6.21 Million CAD | 20.62% |
| 2019 Q4 | 5.56 Million CAD | -10.46% |
| 2019 Q1 | 4.47 Million CAD | -24.23% |
| 2018 Q4 | 5.91 Million CAD | 12.39% |
| 2018 Q2 | 5.9 Million CAD | 32.88% |
| 2018 FY | 21.52 Million CAD | 3.68% |
| 2018 Q1 | 4.44 Million CAD | -24.64% |
| 2018 Q3 | 5.25 Million CAD | -11.0% |
| 2017 Q3 | 5.4 Million CAD | -4.13% |
| 2017 FY | 20.76 Million CAD | 15.85% |
| 2017 Q4 | 5.9 Million CAD | 9.21% |
| 2017 Q2 | 5.63 Million CAD | 47.5% |
| 2017 Q1 | 3.82 Million CAD | -23.72% |
| 2016 Q2 | 4.37 Million CAD | 15.93% |
| 2016 Q4 | 5 Million CAD | 5.1% |
| 2016 Q1 | 3.77 Million CAD | -1.81% |
| 2016 Q3 | 4.76 Million CAD | 9.0% |
| 2016 FY | 17.92 Million CAD | 16.47% |
| 2015 Q1 | 3.3 Million CAD | 8.1% |
| 2015 Q2 | 3.59 Million CAD | 8.71% |
| 2015 FY | 15.38 Million CAD | 26.02% |
| 2015 Q4 | 3.84 Million CAD | -17.31% |
| 2015 Q3 | 4.64 Million CAD | 29.28% |
| 2014 Q4 | 3.05 Million CAD | -15.79% |
| 2014 Q3 | 3.63 Million CAD | 18.22% |
| 2014 Q2 | 3.07 Million CAD | 25.5% |
| 2014 Q1 | 2.44 Million CAD | 14.25% |
| 2014 FY | 12.21 Million CAD | 56.56% |
| 2013 Q1 | 1.54 Million CAD | 16.11% |
| 2013 Q2 | 1.78 Million CAD | 15.88% |
| 2013 Q3 | 2.32 Million CAD | 30.3% |
| 2013 Q4 | 2.14 Million CAD | -7.96% |
| 2013 FY | 7.79 Million CAD | 55.24% |
| 2012 Q4 | 1.32 Million CAD | -15.72% |
| 2012 Q3 | 1.57 Million CAD | 29.56% |
| 2012 Q2 | 1.21 Million CAD | 34.45% |
| 2012 Q1 | 904.48 Thousand CAD | 28.6% |
| 2012 FY | 5.02 Million CAD | 78.88% |
| 2011 Q1 | 478.29 Thousand CAD | 2.82% |
| 2011 FY | 2.8 Million CAD | 67.06% |
| 2011 Q4 | 703.33 Thousand CAD | -28.51% |
| 2011 Q3 | 983.85 Thousand CAD | 52.97% |
| 2011 Q2 | 643.17 Thousand CAD | 34.47% |
| 2010 Q1 | 310.95 Thousand CAD | 162.72% |
| 2010 Q4 | 465.19 Thousand CAD | -24.6% |
| 2010 Q3 | 616.96 Thousand CAD | 114.15% |
| 2010 Q2 | 288.09 Thousand CAD | -7.35% |
| 2010 FY | 1.68 Million CAD | 63.24% |
| 2009 Q1 | 107.05 Thousand CAD | -26.46% |
| 2009 Q4 | 118.35 Thousand CAD | -78.12% |
| 2009 Q2 | 263.62 Thousand CAD | 146.26% |
| 2009 Q3 | 540.87 Thousand CAD | 105.17% |
| 2009 FY | 1.02 Million CAD | -6.54% |
| 2008 FY | 1.1 Million CAD | -0.21% |
| 2008 Q4 | 145.57 Thousand CAD | -66.29% |
| 2008 Q3 | 431.84 Thousand CAD | 82.54% |
| 2008 Q2 | 236.57 Thousand CAD | -17.85% |
| 2008 Q1 | 287.99 Thousand CAD | 430.26% |
| 2007 Q2 | 145.1 Thousand CAD | -52.08% |
| 2007 FY | 1.1 Million CAD | -27.08% |
| 2007 Q1 | 302.84 Thousand CAD | -36.09% |
| 2007 Q4 | 54.31 Thousand CAD | -90.98% |
| 2007 Q3 | 602.06 Thousand CAD | 314.92% |
| 2006 Q1 | 267.77 Thousand CAD | 33.97% |
| 2006 FY | 1.51 Million CAD | 102.33% |
| 2006 Q4 | 473.88 Thousand CAD | -24.45% |
| 2006 Q3 | 627.24 Thousand CAD | 305.72% |
| 2006 Q2 | 154.6 Thousand CAD | -42.27% |
| 2005 Q4 | 199.87 Thousand CAD | -19.53% |
| 2005 Q3 | 248.38 Thousand CAD | 42.16% |
| 2005 FY | 748.52 Thousand CAD | 5.27% |
| 2005 Q1 | 732.35 Thousand CAD | 1016.23% |
| 2005 Q2 | 174.71 Thousand CAD | -76.14% |
| 2004 Q4 | 65.61 Thousand CAD | -72.92% |
| 2004 Q1 | 219.2 Thousand CAD | 230.16% |
| 2004 Q2 | 183.96 Thousand CAD | -16.08% |
| 2004 FY | 711.03 Thousand CAD | -12.53% |
| 2004 Q3 | 242.25 Thousand CAD | 31.68% |
| 2003 Q1 | 95.72 Thousand CAD | 287.54% |
| 2003 FY | 812.84 Thousand CAD | 52.78% |
| 2003 Q4 | 66.39 Thousand CAD | -78.94% |
| 2003 Q3 | 315.25 Thousand CAD | -6.02% |
| 2003 Q2 | 335.46 Thousand CAD | 250.44% |
| 2002 Q1 | 22.03 Thousand CAD | -82.97% |
| 2002 Q2 | 132.72 Thousand CAD | 502.44% |
| 2002 Q4 | 24.7 Thousand CAD | -92.99% |
| 2002 FY | 532.02 Thousand CAD | -20.11% |
| 2002 Q3 | 352.56 Thousand CAD | 165.63% |
| 2001 Q3 | 383.45 Thousand CAD | 369.07% |
| 2001 Q1 | 71.32 Thousand CAD | -58.74% |
| 2001 FY | 665.93 Thousand CAD | -24.95% |
| 2001 Q4 | 129.4 Thousand CAD | -66.25% |
| 2001 Q2 | 81.74 Thousand CAD | 14.62% |
| 2000 Q4 | 172.85 Thousand CAD | -53.22% |
| 2000 Q3 | 369.51 Thousand CAD | 269.51% |
| 2000 Q2 | 100 Thousand CAD | -50.0% |
| 2000 Q1 | 200 Thousand CAD | 0.0% |
| 2000 FY | 887.31 Thousand CAD | 10.91% |
| 1999 Q3 | 500 Thousand CAD | 150.0% |
| 1999 Q4 | - CAD | -100.0% |
| 1999 Q1 | 100 Thousand CAD | 0.0% |
| 1999 FY | 800 Thousand CAD | 14.29% |
| 1999 Q2 | 200 Thousand CAD | 100.0% |
| 1998 Q1 | 300 Thousand CAD | 0.0% |
| 1998 Q4 | - CAD | -100.0% |
| 1998 FY | 700 Thousand CAD | 0.0% |
| 1998 Q3 | 300 Thousand CAD | 50.0% |
| 1998 Q2 | 200 Thousand CAD | -33.33% |
| 1997 Q4 | - CAD | -100.0% |
| 1997 Q3 | 300 Thousand CAD | 0.0% |
| 1997 FY | 700 Thousand CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -12293.408% |
| CanadaBis Capital Inc. | 22.22 Million CAD | -42.155% |
| Decibel Cannabis Company Inc. | 115.95 Million CAD | 72.757% |
| Delivra Health Brands Inc. | 12.37 Million CAD | -155.213% |
| Entourage Health Corp. | 40.71 Million CAD | 22.407% |
| Lifeist Wellness Inc. | 21.65 Million CAD | -45.847% |
| Cannara Biotech Inc. | 57.26 Million CAD | 44.83% |
| Medicure Inc. | 21.69 Million CAD | -45.618% |
| PharmaCielo Ltd. | 1.54 Million CAD | -1948.991% |
| Rubicon Organics Inc. | 40.11 Million CAD | 21.254% |
| Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |